Skip to main content
Premium Trial:

Request an Annual Quote

J&J Joins BioWisdom's Tox Safety Program

NEW YORK (GenomeWeb News) - Johnson & Johnson Pharmaceutical Research & Development will use BioWisdom’s toxicity safety software in drug development programs, BioWisdom said today.
 
Under the three-year agreement, J&J has joined BioWisdom’s Safety Intelligence Program, which uses the company’s Sofia platform to create a “specialist medical search system” for drug safety risk assessment, BioWisdom said.
 
The SIP initiative is aimed at helping drug developers avoid drug-induced adverse events, BioWisdom said.
 
J&J is BioWisdom’s second SIP partner, following AstraZeneca, who joined the program last year.
 
Financial terms of the agreement were not released.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.